US Stock MarketDetailed Quotes

InMed Pharmaceuticals (INM)

Watchlist
  • 0.7100
  • +0.0100+1.43%
Close Apr 17 16:00 ET
  • 0.7100
  • 0.00000.00%
Post 16:04 ET
2.35MMarket Cap-0.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

InMed Pharmaceuticals (INM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
5.03%-2.38M
12.00%-1.61M
-11.18%-7.77M
-72.81%-1.78M
14.21%-1.66M
-35.39%-2.5M
15.98%-1.83M
4.08%-6.99M
-56.42%-1.03M
-16.76%-1.93M
Net income from continuing operations
21.23%-2.03M
-2.92%-1.73M
-6.34%-8.16M
7.71%-1.79M
-23.10%-2.12M
-74.20%-2.58M
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
Operating gains losses
-87.44%1.89K
-74.23%1.36K
519.21%75.93K
221.63%31.05K
1,406.26%24.54K
1,548.85%15.07K
161.15%5.27K
936.52%12.26K
1,110.99%9.66K
5,717.24%1.63K
Depreciation and amortization
22.42%158.02K
8.07%156.68K
-11.55%534.73K
-13.68%131.08K
-14.00%129.58K
-15.42%129.08K
-2.94%144.98K
1.43%604.52K
0.59%151.86K
1.02%150.69K
Other non cash items
----
----
97.20%-35
-2,966.67%-602
671.83%1.44K
26.20%-355
3.53%-519
-55.67%-1.25K
105.11%21
-1,069.23%-252
Change In working capital
-543.98%-602.42K
82.03%-58.96K
8.71%-337.17K
-127.18%-180.88K
163.37%265.42K
86.82%-93.55K
-450.41%-328.16K
34.73%-369.34K
352.62%665.61K
-395.36%-418.82K
-Change in receivables
606.46%159.98K
80.65%122.16K
-24.07%-114.69K
31.31%-99.72K
-163.71%-105.24K
110.94%22.65K
-28.48%67.62K
57.82%-92.44K
-29.85%-145.16K
286.33%165.19K
-Change in inventory
-208.89%-127.09K
190.16%70.37K
327.59%283.15K
-58.66%-147.2K
164.44%289.39K
-46.41%116.72K
-93.79%24.25K
-88.29%66.22K
-399.09%-92.78K
-258.38%-449.11K
-Change in prepaid assets
5.67%-467.04K
-60.47%129.99K
757.72%173.98K
-65.59%186.13K
63.42%154.09K
44.86%-495.1K
16.20%328.87K
-93.22%20.28K
174.35%540.94K
-28.42%94.29K
-Change in payables and accrued expense
-116.23%-58.35K
57.34%-274.07K
-651.50%-249.73K
-101.15%-5.43K
136.88%38.48K
48.98%359.61K
-14.21%-642.39K
105.61%45.28K
312.82%470.73K
-36.45%-104.34K
-Change in other current assets
----
----
--0
--0
--0
--0
--0
-10.88%4.91K
--0
--0
-Change in other current liabilities
-12.83%-109.92K
-0.85%-107.41K
-8.17%-429.88K
-6.05%-114.66K
-15.70%-111.3K
-3.20%-97.42K
-7.90%-106.51K
6.83%-397.42K
0.88%-108.12K
11.24%-96.19K
-Change in other working capital
----
----
----
----
----
----
----
-200.00%-16.17K
--0
---28.66K
Cash from discontinued investing activities
Operating cash flow
5.03%-2.38M
12.00%-1.61M
-11.18%-7.77M
-72.81%-1.78M
14.21%-1.66M
-35.39%-2.5M
15.98%-1.83M
4.08%-6.99M
-56.42%-1.03M
-16.76%-1.93M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
0
0
98.60%-9.29K
0
100.00%-2
Net PPE purchase and sale
----
----
--0
--0
--0
----
----
94.26%-9.29K
--0
100.00%-2
Net business purchase and sale
----
----
----
----
----
----
----
--0
--0
----
Net investment purchase and sale
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
98.60%-9.29K
--0
100.00%-2
Financing cash flow
Cash flow from continuing financing activities
0
-116.37%-137.18K
163.66%12.27M
4,644,531.25%8.17M
2.92M
-92.73%338.52K
838.24K
-56.42%4.65M
176
0
Net common stock issuance
--0
--0
55.87%8.13M
376,907,800.00%3.77M
--2.94M
-92.41%396.15K
--1.03M
-51.16%5.22M
100.15%1
--0
Proceeds from stock option exercised by employees
----
----
2,871,266.29%5.02M
----
----
----
----
-72.91%175
----
----
Net other financing activities
--0
28.49%-137.18K
-57.25%-883.98K
---619.42K
---15.1K
---57.63K
---191.82K
---562.15K
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
-116.37%-137.18K
163.66%12.27M
4,644,531.25%8.17M
--2.92M
-92.73%338.52K
--838.24K
-56.42%4.65M
--176
--0
Net cash flow
Beginning cash position
67.13%9.33M
68.54%11.08M
-26.27%6.57M
-38.43%4.68M
-64.14%3.42M
-17.14%5.58M
-26.27%6.57M
44.29%8.91M
-20.86%7.6M
-16.74%9.53M
Current changes in cash
-9.83%-2.38M
-76.50%-1.74M
292.42%4.5M
721.59%6.4M
165.16%1.26M
-177.37%-2.16M
54.53%-988.57K
-185.57%-2.34M
-48.80%-1.03M
-4.64%-1.93M
End cash Position
103.39%6.95M
67.13%9.33M
68.54%11.08M
68.54%11.08M
-38.43%4.68M
-64.14%3.42M
-17.14%5.58M
-26.27%6.57M
-26.27%6.57M
-20.86%7.6M
Free cash flow
5.03%-2.38M
12.00%-1.61M
-11.03%-7.77M
-72.81%-1.78M
14.21%-1.66M
-34.71%-2.5M
15.98%-1.83M
6.04%-7M
-48.82%-1.03M
-8.38%-1.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 5.03%-2.38M12.00%-1.61M-11.18%-7.77M-72.81%-1.78M14.21%-1.66M-35.39%-2.5M15.98%-1.83M4.08%-6.99M-56.42%-1.03M-16.76%-1.93M
Net income from continuing operations 21.23%-2.03M-2.92%-1.73M-6.34%-8.16M7.71%-1.79M-23.10%-2.12M-74.20%-2.58M33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M
Operating gains losses -87.44%1.89K-74.23%1.36K519.21%75.93K221.63%31.05K1,406.26%24.54K1,548.85%15.07K161.15%5.27K936.52%12.26K1,110.99%9.66K5,717.24%1.63K
Depreciation and amortization 22.42%158.02K8.07%156.68K-11.55%534.73K-13.68%131.08K-14.00%129.58K-15.42%129.08K-2.94%144.98K1.43%604.52K0.59%151.86K1.02%150.69K
Other non cash items --------97.20%-35-2,966.67%-602671.83%1.44K26.20%-3553.53%-519-55.67%-1.25K105.11%21-1,069.23%-252
Change In working capital -543.98%-602.42K82.03%-58.96K8.71%-337.17K-127.18%-180.88K163.37%265.42K86.82%-93.55K-450.41%-328.16K34.73%-369.34K352.62%665.61K-395.36%-418.82K
-Change in receivables 606.46%159.98K80.65%122.16K-24.07%-114.69K31.31%-99.72K-163.71%-105.24K110.94%22.65K-28.48%67.62K57.82%-92.44K-29.85%-145.16K286.33%165.19K
-Change in inventory -208.89%-127.09K190.16%70.37K327.59%283.15K-58.66%-147.2K164.44%289.39K-46.41%116.72K-93.79%24.25K-88.29%66.22K-399.09%-92.78K-258.38%-449.11K
-Change in prepaid assets 5.67%-467.04K-60.47%129.99K757.72%173.98K-65.59%186.13K63.42%154.09K44.86%-495.1K16.20%328.87K-93.22%20.28K174.35%540.94K-28.42%94.29K
-Change in payables and accrued expense -116.23%-58.35K57.34%-274.07K-651.50%-249.73K-101.15%-5.43K136.88%38.48K48.98%359.61K-14.21%-642.39K105.61%45.28K312.82%470.73K-36.45%-104.34K
-Change in other current assets ----------0--0--0--0--0-10.88%4.91K--0--0
-Change in other current liabilities -12.83%-109.92K-0.85%-107.41K-8.17%-429.88K-6.05%-114.66K-15.70%-111.3K-3.20%-97.42K-7.90%-106.51K6.83%-397.42K0.88%-108.12K11.24%-96.19K
-Change in other working capital -----------------------------200.00%-16.17K--0---28.66K
Cash from discontinued investing activities
Operating cash flow 5.03%-2.38M12.00%-1.61M-11.18%-7.77M-72.81%-1.78M14.21%-1.66M-35.39%-2.5M15.98%-1.83M4.08%-6.99M-56.42%-1.03M-16.76%-1.93M
Investing cash flow
Cash flow from continuing investing activities 000000098.60%-9.29K0100.00%-2
Net PPE purchase and sale ----------0--0--0--------94.26%-9.29K--0100.00%-2
Net business purchase and sale ------------------------------0--0----
Net investment purchase and sale --0--0--0--0--0--0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--098.60%-9.29K--0100.00%-2
Financing cash flow
Cash flow from continuing financing activities 0-116.37%-137.18K163.66%12.27M4,644,531.25%8.17M2.92M-92.73%338.52K838.24K-56.42%4.65M1760
Net common stock issuance --0--055.87%8.13M376,907,800.00%3.77M--2.94M-92.41%396.15K--1.03M-51.16%5.22M100.15%1--0
Proceeds from stock option exercised by employees --------2,871,266.29%5.02M-----------------72.91%175--------
Net other financing activities --028.49%-137.18K-57.25%-883.98K---619.42K---15.1K---57.63K---191.82K---562.15K--0--0
Cash from discontinued financing activities
Financing cash flow --0-116.37%-137.18K163.66%12.27M4,644,531.25%8.17M--2.92M-92.73%338.52K--838.24K-56.42%4.65M--176--0
Net cash flow
Beginning cash position 67.13%9.33M68.54%11.08M-26.27%6.57M-38.43%4.68M-64.14%3.42M-17.14%5.58M-26.27%6.57M44.29%8.91M-20.86%7.6M-16.74%9.53M
Current changes in cash -9.83%-2.38M-76.50%-1.74M292.42%4.5M721.59%6.4M165.16%1.26M-177.37%-2.16M54.53%-988.57K-185.57%-2.34M-48.80%-1.03M-4.64%-1.93M
End cash Position 103.39%6.95M67.13%9.33M68.54%11.08M68.54%11.08M-38.43%4.68M-64.14%3.42M-17.14%5.58M-26.27%6.57M-26.27%6.57M-20.86%7.6M
Free cash flow 5.03%-2.38M12.00%-1.61M-11.03%-7.77M-72.81%-1.78M14.21%-1.66M-34.71%-2.5M15.98%-1.83M6.04%-7M-48.82%-1.03M-8.38%-1.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -